Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity
To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor. In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were...
Gespeichert in:
Veröffentlicht in: | European urology 2004-12, Vol.46 (6), p.776-783 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 783 |
---|---|
container_issue | 6 |
container_start_page | 776 |
container_title | European urology |
container_volume | 46 |
creator | Giannitsas, K. Perimenis, P. Athanasopoulos, A. Gyftopoulos, K. Nikiforidis, G. Barbalias, G. |
description | To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor.
In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition.
107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant (
p > 0.05). In group II neither of the drugs achieved significant changes in the outcome measure (
p > 0.05).
Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different. |
doi_str_mv | 10.1016/j.eururo.2004.07.021 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67088651</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283804003756</els_id><sourcerecordid>67088651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</originalsourceid><addsrcrecordid>eNp9kM1q3DAUhUVpaSY_b1CKVt3ZuZL8I28KZZImgcAsmqyFLF0TDWNrKslDve-DV8MMdBcQCKHvnMv9CPnCoGTAmtttiXOYgy85QFVCWwJnH8iKyVYUbd3AR7ICAbzgUsgLchnjFgBE3YnP5ILVdSWrql2Rv2s_7nVw0U_UDzS9Ib0fBme0WY7vF79LGLx1E1I9Wbr5s_RzWiY30Xzu3DBgwCnR18wskx6dob_wgMGlhT4EbTEeW56s83ud3vLvHaYwRx_oJlPaJHfI6DX5NOhdxJvzfUVef96_rB-L583D0_rHc2GEFKnoejb02DUMgbeAVYcMG45NbwUgl1YzqaGrWCs1ZzUXnWWiMYYNhleCWS2uyLdT7z743zPGpEYXDe52ekI_R9W0IGVTswxWJ9AEH2PAQe2DG3VYFAN1tK-26mRfHe0raFW2n2Nfz_1zP6L9HzrrzsD3E4B5y4PDoKJxOBm0LqBJynr3_oR_wDKawA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67088651</pqid></control><display><type>article</type><title>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Giannitsas, K. ; Perimenis, P. ; Athanasopoulos, A. ; Gyftopoulos, K. ; Nikiforidis, G. ; Barbalias, G.</creator><creatorcontrib>Giannitsas, K. ; Perimenis, P. ; Athanasopoulos, A. ; Gyftopoulos, K. ; Nikiforidis, G. ; Barbalias, G.</creatorcontrib><description>To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor.
In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition.
107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant (
p > 0.05). In group II neither of the drugs achieved significant changes in the outcome measure (
p > 0.05).
Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2004.07.021</identifier><identifier>PMID: 15548447</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Benzhydryl Compounds - therapeutic use ; Cresols - therapeutic use ; Cross-Over Studies ; Female ; Humans ; Mandelic Acids - therapeutic use ; Middle Aged ; Muscarinic Antagonists - therapeutic use ; Overactive bladder ; Oxybutynin ; Phenylpropanolamine - therapeutic use ; Severity ; Severity of Illness Index ; Tolterodine ; Tolterodine Tartrate ; Treatment ; Urinary Incontinence - drug therapy ; Urinary Incontinence - physiopathology ; Urodynamics</subject><ispartof>European urology, 2004-12, Vol.46 (6), p.776-783</ispartof><rights>2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</citedby><cites>FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2004.07.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15548447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giannitsas, K.</creatorcontrib><creatorcontrib>Perimenis, P.</creatorcontrib><creatorcontrib>Athanasopoulos, A.</creatorcontrib><creatorcontrib>Gyftopoulos, K.</creatorcontrib><creatorcontrib>Nikiforidis, G.</creatorcontrib><creatorcontrib>Barbalias, G.</creatorcontrib><title>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor.
In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition.
107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant (
p > 0.05). In group II neither of the drugs achieved significant changes in the outcome measure (
p > 0.05).
Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Benzhydryl Compounds - therapeutic use</subject><subject>Cresols - therapeutic use</subject><subject>Cross-Over Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Mandelic Acids - therapeutic use</subject><subject>Middle Aged</subject><subject>Muscarinic Antagonists - therapeutic use</subject><subject>Overactive bladder</subject><subject>Oxybutynin</subject><subject>Phenylpropanolamine - therapeutic use</subject><subject>Severity</subject><subject>Severity of Illness Index</subject><subject>Tolterodine</subject><subject>Tolterodine Tartrate</subject><subject>Treatment</subject><subject>Urinary Incontinence - drug therapy</subject><subject>Urinary Incontinence - physiopathology</subject><subject>Urodynamics</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1q3DAUhUVpaSY_b1CKVt3ZuZL8I28KZZImgcAsmqyFLF0TDWNrKslDve-DV8MMdBcQCKHvnMv9CPnCoGTAmtttiXOYgy85QFVCWwJnH8iKyVYUbd3AR7ICAbzgUsgLchnjFgBE3YnP5ILVdSWrql2Rv2s_7nVw0U_UDzS9Ib0fBme0WY7vF79LGLx1E1I9Wbr5s_RzWiY30Xzu3DBgwCnR18wskx6dob_wgMGlhT4EbTEeW56s83ud3vLvHaYwRx_oJlPaJHfI6DX5NOhdxJvzfUVef96_rB-L583D0_rHc2GEFKnoejb02DUMgbeAVYcMG45NbwUgl1YzqaGrWCs1ZzUXnWWiMYYNhleCWS2uyLdT7z743zPGpEYXDe52ekI_R9W0IGVTswxWJ9AEH2PAQe2DG3VYFAN1tK-26mRfHe0raFW2n2Nfz_1zP6L9HzrrzsD3E4B5y4PDoKJxOBm0LqBJynr3_oR_wDKawA</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Giannitsas, K.</creator><creator>Perimenis, P.</creator><creator>Athanasopoulos, A.</creator><creator>Gyftopoulos, K.</creator><creator>Nikiforidis, G.</creator><creator>Barbalias, G.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</title><author>Giannitsas, K. ; Perimenis, P. ; Athanasopoulos, A. ; Gyftopoulos, K. ; Nikiforidis, G. ; Barbalias, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Benzhydryl Compounds - therapeutic use</topic><topic>Cresols - therapeutic use</topic><topic>Cross-Over Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Mandelic Acids - therapeutic use</topic><topic>Middle Aged</topic><topic>Muscarinic Antagonists - therapeutic use</topic><topic>Overactive bladder</topic><topic>Oxybutynin</topic><topic>Phenylpropanolamine - therapeutic use</topic><topic>Severity</topic><topic>Severity of Illness Index</topic><topic>Tolterodine</topic><topic>Tolterodine Tartrate</topic><topic>Treatment</topic><topic>Urinary Incontinence - drug therapy</topic><topic>Urinary Incontinence - physiopathology</topic><topic>Urodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giannitsas, K.</creatorcontrib><creatorcontrib>Perimenis, P.</creatorcontrib><creatorcontrib>Athanasopoulos, A.</creatorcontrib><creatorcontrib>Gyftopoulos, K.</creatorcontrib><creatorcontrib>Nikiforidis, G.</creatorcontrib><creatorcontrib>Barbalias, G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giannitsas, K.</au><au>Perimenis, P.</au><au>Athanasopoulos, A.</au><au>Gyftopoulos, K.</au><au>Nikiforidis, G.</au><au>Barbalias, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>46</volume><issue>6</issue><spage>776</spage><epage>783</epage><pages>776-783</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><abstract>To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor.
In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition.
107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant (
p > 0.05). In group II neither of the drugs achieved significant changes in the outcome measure (
p > 0.05).
Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>15548447</pmid><doi>10.1016/j.eururo.2004.07.021</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0302-2838 |
ispartof | European urology, 2004-12, Vol.46 (6), p.776-783 |
issn | 0302-2838 1873-7560 |
language | eng |
recordid | cdi_proquest_miscellaneous_67088651 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Aged Aged, 80 and over Benzhydryl Compounds - therapeutic use Cresols - therapeutic use Cross-Over Studies Female Humans Mandelic Acids - therapeutic use Middle Aged Muscarinic Antagonists - therapeutic use Overactive bladder Oxybutynin Phenylpropanolamine - therapeutic use Severity Severity of Illness Index Tolterodine Tolterodine Tartrate Treatment Urinary Incontinence - drug therapy Urinary Incontinence - physiopathology Urodynamics |
title | Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A00%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Efficacy%20of%20Tolterodine%20and%20Oxybutynin%20in%20Different%20Urodynamic%20Severity%20Grades%20of%20Idiopathic%20Detrusor%20Overactivity&rft.jtitle=European%20urology&rft.au=Giannitsas,%20K.&rft.date=2004-12-01&rft.volume=46&rft.issue=6&rft.spage=776&rft.epage=783&rft.pages=776-783&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2004.07.021&rft_dat=%3Cproquest_cross%3E67088651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67088651&rft_id=info:pmid/15548447&rft_els_id=S0302283804003756&rfr_iscdi=true |